Market Size – USD 2.315 Billion in 2018, Market Growth - CAGR of
8.8%, Market Trends – Product launches and research for advanced Nucleic Acid
Amplification Testing
According to the current analysis of Reports and Data, the
global Nucleic Acid
Amplification Testing (NAAT) market was valued at USD 2.315
Billion in 2018 and is expected to reach USD 4.549 Billion by year 2026, at a
CAGR of 8.8 %. The study covers Nucleic acid which a complex organic substance
essential to all forms of life. It is present in living cells as RNA and DNA, composed
of nucleotides linked in a long chain. Whereas, Nucleic acid amplification
testing is a method of testing the blood to detect pathogen causing bacteria or
virus in in blood, tissue, urine, etc.
The nucleic acid amplification testing is widely used in the field
of diagnostics. With market players exploring the applications of nucleic acid
amplification testing, and it is expected to be adopted in new disease fields
for the diagnostics and monitoring purpose. For instance, Gen-Probe, Inc., a US
based Clinical Diagnostics company, introduced three assays based on its
transcription-mediated amplification technology: the APTIMA CT assay (ACT),
which detects C. trachomatis, the APTIMA GC assay (AGC), which detects
Neisseria gonorrhoeae, and the APTIMA COMBO 2 assay (AC2), which detects both
pathogens.
Request for FREE sample of this
premium report @ https://www.reportsanddata.com/sample-enquiry-form/2187
 |
| Nucleic Acid Amplification Testing (NAAT) Market | Reports and Data |
Increasing need for advanced diagnostic methods, wide range of
applications in identification and monitoring of numerous diseases, increasing
investment in the diagnostics sector, initiatives by governments all over the
globe, extensive range of uses, growing demand from blood banks and transfusion
centers, technological development in healthcare sector, are some of the
prominent factors propelling nucleic acid amplification testing market growth
in the industry.
However, associated safety concerns related to the nucleic acid
amplification testing process, and dearth of sophisticated infrastructure
essential for these kind of advanced technology in some developing nations, are
the major hindrances restraining the nucleic acid amplification testing market
growth during 2019-2026.
Further key findings from the
report suggest
- Nucleic Acid Amplification
testing market is growing at a CAGR of 8 % in Asia Pacific followed by
North America and Europe, with 8.6 % and 8.5 % CAGR, respectively. Growing
demand for the advanced diagnostic measures the globe is the prominent
factor to accelerate the nucleic acid amplification testing market growth
during forecast period across all regions
- As of 2018, Target Amplification
system is the dominating Nucleic Acid Amplification Testing technique
which holds 38.8 % of the global market. North America regional market is
the chief revenue generating source for this product segment, followed by
Europe and Asia-Pacific regions.
- Probe amplification systems is
expected to grow at a CAGR of 8.4 %. The market segment will reach USD 1.5
Billion mark by 2026.
- Infectious disease application
type segment was valued at USD 1.03 billion and is expected reach USD 1.97
billion by 2026, growing at a CAGR of 8.7%.
- Asia Pacific is expected to
account for the 22.5 % of the global Nucleic Acid Amplification Testing
market. Developing nations such China, and India are likely to witness
significant growth
- Associated safety concerns
related to the nucleic acid amplification testing process and dearth of
sophisticated infrastructure essential for these kind of advanced
technology is likely to hinder the nucleic acid amplification testing
market growth during the forecast period
- Key participants include Siemens
Healthcare GmbH, Abbott Laboratories, Inc., F. Hoffmann-La Roche Ltd,
Grifols SA, Becton, Illumina Inc., Dickinson and Company, Beckman Coulter
Inc., Bio-Rad Laboratories, and bioMrieux SA
To
identify the key trends in the industry, click on the link below: https://www.reportsanddata.com/report-detail/nucleic-acid-amplification-testing-naat-market
Segments covered in the report
This report forecasts revenue growth at a global, regional &
country level, and provides an analysis of the market trends in each of the
sub-segments from 2016 to 2026. For the purpose of this study, Reports and Data
have segmented the Nucleic Acid Amplification Testing market on the basis of
Technique type, Application type, and region:
Technique Type (Revenue, USD Million; 2016–2026)
- Target Amplification
- Probe Amplification
- Signal Amplification
Application Type (Revenue, USD Million; 2016–2026)
- Infectious Diseases
- Cancer
- Personalized Medicine
- Genetic
Regional Outlook (Revenue in USD Million; 2016–2026)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Spain
- Benelux
- Italy
- Rest of the Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Taiwan
- Australia
- Rest of Asia-Pacific
- Middle East & Africa
- Saudi Arabia
- South Africa
- Egypt
- Israel
- Rest of MEA
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Ask for Discount @ https://www.reportsanddata.com/discount-enquiry-form/2187
About
Us:
Reports and Data is a market research
and consulting company that provides syndicated research reports, customized
research reports, and consulting services. Our solutions purely focus on your
purpose to locate, target and analyze consumer behavior shifts across
demographics, across industries and help client’s make a smarter business
decision. We offer market intelligence studies ensuring relevant and fact-based
research across a multiple industries including Healthcare, Technology,
Chemicals, Types, and Energy. We consistently update our research offerings to
ensure our clients are aware about the latest trends existent in the market.
Contact Us:
John Watson
Head of Business Development
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
No comments:
Post a Comment